Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Willibald

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
EJNMMI Research|April 29, 2015
Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATEMargret Schottelius, Jakub Šimeček, Frauke Hoffmann, et al.
The Journal of Biological Chemistry|February 26, 2016
Aggregation Limits Surface Expression of Homomeric GluA3 ReceptorsSarah K Coleman, Ying Hou, Marina Willibald, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 26, 2015
May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?Ying Zhang, Xiangyan Ruan, Marina Willibald, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 13, 2017
High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant TherapyMarina Willibald, Isabel Wurster, Christoph Meisner, et al.
Menopause (New York, N.Y.)|October 18, 2016
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancerXiangyan Ruan, Ying Zhang, Alfred O Mueck, et al.
Oncotarget|October 27, 2017
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cellsMarina Willibald, Giuliano Bayer, Vanessa Stahlhut, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
EJNMMI Research|April 29, 2015
Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATEMargret Schottelius, Jakub Šimeček, Frauke Hoffmann, et al.
The Journal of Biological Chemistry|February 26, 2016
Aggregation Limits Surface Expression of Homomeric GluA3 ReceptorsSarah K Coleman, Ying Hou, Marina Willibald, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 26, 2015
May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?Ying Zhang, Xiangyan Ruan, Marina Willibald, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 13, 2017
High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant TherapyMarina Willibald, Isabel Wurster, Christoph Meisner, et al.
Menopause (New York, N.Y.)|October 18, 2016
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancerXiangyan Ruan, Ying Zhang, Alfred O Mueck, et al.
Oncotarget|October 27, 2017
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cellsMarina Willibald, Giuliano Bayer, Vanessa Stahlhut, et al.
Pageof 1